(RTTNews) - Actinium Pharmaceuticals, Inc. (ATNM) announced that results from the clinical trial evaluating Actimab-A in combination with the chemotherapy CLAG-M in patients with relapsed/refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback